Life Science Instrumentation Market by Technology [Spectroscopy, Chromatography, Flow Cytometry, NGS, PCR,, Microscopy], Application (Research, Clinical), End User (Pharma-Biotech, Agri and Food Industry, Hospitals & Diagnostic Labs)-Global Forecasts to 2025

ライフサイエンス機器の世界市場予測:技術別(分光法、クロマトグラフィー、フローサイトメトリー、NGS、PCR、顕微鏡法)、用途別(研究、臨床)、エンドユーザー別(製薬バイオテクノロジー、農業・食品産業、病院・診断ラボ)

◆タイトル:Life Science Instrumentation Market by Technology [Spectroscopy, Chromatography, Flow Cytometry, NGS, PCR,, Microscopy], Application (Research, Clinical), End User (Pharma-Biotech, Agri and Food Industry, Hospitals & Diagnostic Labs)-Global Forecasts to 2025
◆商品コード:AST 4499
◆調査・発行会社:MarketsandMarkets
◆発行日:2020年4月30日
◆ページ数:307
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:産業機械
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥534,600見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥718,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥880,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarkets社はライフサイエンス機器の世界市場が、2020年600億ドルから2025年799億ドルまで、年平均5.9%成長すると予測しています。本調査レポートでは、ライフサイエンス機器の世界市場を広く調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場動向、技術別(分光法、クロマトグラフィー、フローサイトメトリー、NGS、PCR、顕微鏡法)分析、用途別(研究、臨床、その他)分析、エンドユーザー別(病院・診断研究所、製薬・バイオテクノロジー企業、学術研究機関、農業・食品産業、環境試験ラボ)分析、地域別分析、競争状況、企業概要などを含め、今後の方向性を提示しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場動向
・ライフサイエンス機器の世界市場:技術別(分光法、クロマトグラフィー、フローサイトメトリー、NGS、PCR、顕微鏡法)
・ライフサイエンス機器の世界市場:用途別(研究、臨床、その他)
・ライフサイエンス機器の世界市場:エンドユーザー別(病院・診断研究所、製薬・バイオテクノロジー企業、学術研究機関、農業・食品産業、環境試験ラボ)
・ライフサイエンス機器の世界市場:地域別
・競争状況
・企業概要

“The life science instrumentation market is projected to grow at a CAGR of 5.9% during the forecast period”
The global life science instrumentation market size is projected to reach USD 79.9 billion by 2025 from USD 60.0 billion in 2020, at a CAGR of 5.9%. The growth of the market is attributed to increasing spending on pharmaceutical R&D, growing food safety concerns, technological advancements in analytical instruments, and the availability of funding for life science research. Moreover, the growing proteomics market, rising environmental safety concerns, increasing demand for analytical instruments in several industries, and high demand in emerging nations offer lucrative opportunities for the market players. However, the dearth of skilled professionals and the high cost of technologically advanced instruments are the major factors that are expected to restrain the growth of this market during the forecast period.

“The spectroscopy segment is expected to account for the largest market share during the forecast period.”
Based on technology, the market is segmented into spectroscopy, chromatography, PCR, immunoassays, lyophilization, liquid handling, clinical chemistry analyzers, microscopy, flow cytometry, next-generation sequencing (NGS), centrifuges, electrophoresis, cell counting, and other technologies. The spectroscopy accounted for the largest share of this market in 2019, driven by increased spending on R&D in pharmaceutical companies, government regulations on drug safety, and growing focus on the quality of food products.

“The molecular spectroscopy segment to hold a major share of the life science instrumentation market during the forecast period.”
Based on type, the spectrometry market is segmented into three major types—mass spectrometers, molecular spectrometers, and atomic spectrometers. The wide application of this technology and the presence of stringent regulatory guidelines for drug development and safety are driving the growth of the molecular spectrometry segment.

“Europe to account for the second-largest share of the global market in 2019”
The life science instrumentation market is segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. Europe accounted for the second-largest share of the global life science instrumentation market in 2019. Direct & indirect financial investments in analytical instruments, rising healthcare expenditure, an increase in research activity & academia-industry partnerships, and conferences & symposia related to analytical technologies are the key factors driving market growth in the region. Moreover, the rising incidence of infectious diseases and favorable government initiatives are playing a vital role.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–45%, Tier 2–34%, and Tier 3– 21%
• By Designation: C-level–47%, Director-level–33%, and Others–20%
• By Region: North America–35%, Europe–32%, Asia Pacific–25%, Latin America–6%, and the Middle East & Africa–2%

The major players in the market include Agilent Technologies (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories, Inc. (US), Bruker Corporation (US), Danaher Corporation (US), Eppendorf AG (Germany), GE Healthcare (US), Hitachi High-Technologies Corporation (Japan), Horiba (Japan), Merck KGaA (Germany), PerkinElmer, Inc.. (US), Qiagen N.V. (Netherlands), Shimadzu Corporation (Japan), Thermo Fisher Scientific, Inc. (US), and Waters Corporation (US)., among others.

Research Coverage
This report studies the life science instrumentation market based on technology, application, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:
 Market Penetration: Comprehensive information on the product portfolios offered by the top players in the life science instrumentation market
 Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the life science instrumentation market
 Market Development: Comprehensive information on lucrative emerging regions
 Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the life science instrumentation market
 Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

【レポートの目次】



★調査レポート[ライフサイエンス機器の世界市場予測:技術別(分光法、クロマトグラフィー、フローサイトメトリー、NGS、PCR、顕微鏡法)、用途別(研究、臨床)、エンドユーザー別(製薬バイオテクノロジー、農業・食品産業、病院・診断ラボ)] ( Life Science Instrumentation Market by Technology [Spectroscopy, Chromatography, Flow Cytometry, NGS, PCR,, Microscopy], Application (Research, Clinical), End User (Pharma-Biotech, Agri and Food Industry, Hospitals & Diagnostic Labs)-Global Forecasts to 2025 / AST 4499) 販売に関する免責事項
[ライフサイエンス機器の世界市場予測:技術別(分光法、クロマトグラフィー、フローサイトメトリー、NGS、PCR、顕微鏡法)、用途別(研究、臨床)、エンドユーザー別(製薬バイオテクノロジー、農業・食品産業、病院・診断ラボ)] ( Life Science Instrumentation Market by Technology [Spectroscopy, Chromatography, Flow Cytometry, NGS, PCR,, Microscopy], Application (Research, Clinical), End User (Pharma-Biotech, Agri and Food Industry, Hospitals & Diagnostic Labs)-Global Forecasts to 2025 / AST 4499) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆